Could Flumazenil Be Used Pre-hospital by Intramuscular Injection for Coma due to Mixed Drug Overdose Not Responding to Naloxone?: A Systematic Review of the Evidence.
Basic & clinical pharmacology & toxicology · 2025-02-14 · Systematic review
Abstract
BACKGROUND/RATIONALE: Benzodiazepine-involved overdose deaths are increasing. Flumazenil is rarely used due to fear of seizures; however, the risk benefit may favour its use. Flumazenil is licensed for intravenous (IV) use, but intramuscular (IM) treatment would be required pre-hospital. OBJECTIVE: To identify and synthesise pre-clinical and clinical data on the parenteral IM flumazenil safety and efficacy. METHODS: PubMed, Google Scholar, Cochrane and Scopus searches without any language restriction. Adverse effect studies were limited to systematic reviews and large cohort studies (n > 100), IM administration efficacy to studies in large animal (mammalian, excluding reptiles and birds) and humans. RESULTS: Two systematic reviews reported adverse effects from IV or IM flumazenil in clinical use and combined retrospective/prospective patient cohort. Seizures were uncommon (< 2%) including mixed overdoses. Seven studies (four animal, three human) reported on IM flumazenil. Animal studies indicated IM flumazenil efficacy. In a canine cross-over study, IM flumazenil reversed midazolam sedation moderately slower than IV. Two clinical observational studies reported sedation reversal with IM flumazenil, whereas a cross-over study found no IM flumazenil response at 15 min. CONCLUSION: IM flumazenil data are sparse, but it may be effective and safe. Clinical research is urgently needed to determine whether pre-hospital IM flumazenil can prevent benzodiazepine-involved overdose deaths.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Sedatives & anxiolytics · Midazolam · Antidotes · Other benzodiazepines & Z-drugs · Naloxone · Flumazenil
Related articles
- Prehospital Flumazenil: Five-Year Review of Use, Indications, Outcomes, and Adverse Events in Suspected Benzodiazepine Overdose. (West J Emerg Med, 2026)
- 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. (Circulation, 2023)
- Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. (Clin Toxicol (Phila), 2007)
- Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department? (Resuscitation, 2007)
- Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings. (Am J Health Syst Pharm, 2015)
- Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial. (Eur J Clin Pharmacol, 2021)